
Fabian Kerwagen
Articles
-
Nov 6, 2023 |
thelancet.com | Fabian Kerwagen |Rolf Wachter |Stephan von Haehling |Uwe Riemer
Research in contextGuideline-directed medical therapy (GDMT) is the cornerstone of a successful treatment strategy in patients with heart failure and reduced ejection fraction (HFrEF). Besides established pharmacotherapy, novel substances such as sacubitril/valsartan (S/V) and sodium-glucose co-transporter-2 inhibitors (SGLT2i) have demonstrated marked clinical benefits.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →